Clinical Trial Update: A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC) [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating alisertib in combination with paclitaxel for small cell lung cancer, which is currently not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Alisertib (alisertib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Puma Biotechnology, Inc. | Conditions: Small Cell Lung Cancer ( SCLC ) | Phase 2 | Status: NOT_YET_RECRUITING